Federal grants to Adrx, Inc.
Adrx, Inc. in Thousand Oaks, California received $1.0 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Aging Research, with $476,551. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$1.0 million
- Awards3
- Awarded in FY 2025$0
- Largest award$476,551
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 3 | $1.0 million |
| FY 2023 | 0 | $0 |
| FY 2024 | 0 | $0 |
| FY 2025 | 0 | $0 |
Programs that fund Adrx, Inc.
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 1 | $476,551 |
| National Center for Advancing Translational Sciences | 1 | $270,276 |
| Biomedical Research and Research Training | 1 | $256,083 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $1.0 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Brain-penetrant chemical disaggregators of tau fibrils as therapeutics for alzheimer's disease - abstract alzheimer’s disease is a multifactorial disease in which numerous mechanisms culminate in neuronal death, brain atrophy and progressive dementia. The duration of alzheimer’s disease-related deme | Aging Research | July 22, 2022 | $476,551 |
| Development of a blood-based diagnostic for early detection of transthyretin amyloidosis - abstract transthyretin amyloidosis (ATTR) is a rare, progressive, and ultimately fatal condition characterized by the abnormal extracellular deposition of transthyretin (TTR) protein within the peripheral nerv | National Center for Advancing Translational Sciences | July 29, 2022 | $270,276 |
| Therapeutic immunodepletion of a transthyretin aggregation intermediate - abstract transthyretin amyloidosis (ATTR) is a rare, progressive, and ultimately fatal condition characterized by the abnormal extracellular deposition of transthyretin (TTR) protein within the peripheral nerves (attr-pn) and/ | Biomedical Research and Research Training | May 31, 2022 | $256,083 |
Questions people ask
How much federal grant money does Adrx, Inc. get?
$1.0 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Adrx, Inc. the most?
The Department of Health and Human Services, with $1.0 million in 3 awards.
What is Adrx, Inc.'s largest federal grant?
$476,551 under Aging Research, with its first action in the period on July 22, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Adrx, Inc.?
Its largest are Aging Research, National Center for Advancing Translational Sciences and Biomedical Research and Research Training.
Other grant recipients in Thousand Oaks
- California Lutheran University
- Teledyne Scientific & Imaging, LLC
- Santa Monica Mountains Fund
- Conejo Valley Unified School District
- Actiox LLC
- City of Thousand Oaks
- Many Mansions, a California Nonprofit Corporation
- Monopole Research
Largest federal grant recipients in California · Federal grants in California